Literature DB >> 3547567

Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection.

T F Murphy, M A Apicella.   

Abstract

Nontypable Haemophilus influenzae has now become well established as an important pathogen in both adults and children. Recent work has identified clear distinctions between nontypable and type b strains of H. influenzae. These organisms affect different patient populations, cause different infections, present different surface antigens to the host, and are genetically different. The commonest clinical manifestation of infection due to nontypable H. influenzae in adults is lower respiratory tract infection, particularly in the elderly and in those with chronic bronchitis. The bacterium is a frequent cause of acute otitis media in children. The surface of nontypable H. influenzae is composed of outer-membrane proteins and lipooligosaccharide, and both of these demonstrate substantial antigenic heterogeneity, which can be used to serotype isolates. Some respiratory tract isolates are fimbriated, but the role of fimbriae in pathogenesis is unclear. Antibodies to outer-membrane proteins and lipooligosaccharide are present in human serum. Investigation of human immunity to infection is focusing on identification of those antigens to which protective antibody is directed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3547567     DOI: 10.1093/clinids/9.1.1

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  119 in total

1.  Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein.

Authors:  W El-Adhami; J M Kyd; D A Bastin; A W Cripps
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung.

Authors:  D C Webb; A W Cripps
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Neonatal, urogenital isolates of biotype 4 nontypeable Haemophilus influenzae express a variant P6 outer membrane protein molecule.

Authors:  T F Murphy; C Kirkham; D J Sikkema
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  DNA probe technology for rapid detection of Haemophilus influenzae in clinical specimens.

Authors:  F Malouin; L E Bryan; P Shewciw; J Douglas; D Li; H Van den Elzen; J R Lapointe
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

5.  Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo.

Authors:  Wenzhou Hong; Bing Pang; Shayla West-Barnette; W Edward Swords
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

6.  Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae.

Authors:  W Edward Swords; Miranda L Moore; Luciana Godzicki; Gail Bukofzer; Michael J Mitten; Jessica VonCannon
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Distribution of Haemophilus influenzae and Haemophilus parainfluenzae biotypes isolated from the human genitourinary tract.

Authors:  E B Drouet; G A Denoyel; M M Boude; G Boussant; H P de Montclos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267

8.  Diversity of the P2 protein among nontypeable Haemophilus influenzae isolates.

Authors:  J Bell; S Grass; D Jeanteur; R S Munson
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.

Authors:  Stacey M Hartwig; Margaret Ketterer; Michael A Apicella; Steven M Varga
Journal:  Virology       Date:  2016-08-27       Impact factor: 3.616

10.  Mapping of a surface-exposed, conformational epitope of the P6 protein of Haemophilus influenzae.

Authors:  J A Bogdan; M A Apicella
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.